-
Congratulations to the Graduating Class of 2025!
On May 30th, I had the opportunity to speak to the graduating dietetic interns at Children’s Hospital Colorado, sharing my journey from clinical care to entrepreneurship in diabetes care and education. Here are…
-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss. To better assess…
-
GLP-1 Success Starts with Dietitian Leadership
It should come as no surprise that a large part of the success with incretin-based therapies— like Ozempic, Wegovy, Mounjaro, and Zepbound—stems from the effective integration of lifestyle modifications, particularly nutrition. This success…
-
What Is Type 5 Diabetes? Exploring the Newest Diagnostic Category
If you’ve seen a new diabetes diagnosis category circulating in medical circles and found yourself confused, thinking, “I don’t remember learning about that type in medical, nursing, or dietetics school,” don’t worry. It’s…
-
DCES Leadership in the Future of Wearable Health Technology
In a recent issue of Healthcare150, a newsletter spotlighting key healthcare trends, I was struck by the projected growth of wearable devices—from $14.5 billion in 2020 to $76.1 billion by 2029. In my…
Diabetes Care and Education
